Authors retract two statin papers, one with problems “too extensive to revise”

Researchers in China have retracted two 2016 papers about the possible use of a cholesterol-lowering agent to treat bleeding on the brain.

One of the retracted papers in the Journal of Neurosurgery (JNS) had multiple problems that were “too extensive to revise,” according to the lengthy retraction notice, relating to issues with authorship, data analyses, and patient enrollment. The notice is signed by first author Hua Liu of the Nanjing Medical University in China.

Liu is also the first author of another recently retracted paper in Frontiers in Neuroscience, pulled for incorrectly categorizing patients.

The JNS retraction notice begins: Continue reading Authors retract two statin papers, one with problems “too extensive to revise”

Neuroscience paper retracted after colleagues object to data publication

frontiersA paper published this October in the journal Frontiers In Neuroscience was retracted the following month because the authors’ collaborators did not give them permission to publish some of the data.

The paper detailed how and why the authors use the software program Nengo to test large simulations of nervous system networks. As part of the research, the authors tested five systems, one of which they were working on with another group. Due to a “miscommunication,” the authors thought they had received permission to publish the data; they plan to resubmit a paper describing the other four systems.

Here’s the official retraction note: Continue reading Neuroscience paper retracted after colleagues object to data publication